| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_876b4b58efbaf3319ed4cfa448a36f44 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-366 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
2012-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18a836873c3219a16aa912dfec8e0dd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01f87955cf96c6643674cf30f4a98e4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d99ba262181f5f15a16cb18e1c5828e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0101a33541f03f792c772375cad8e9a |
| publicationDate |
2016-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2854882-C |
| titleOfInvention |
Medicament for therapeutic treatment and/or improvement of sepsis |
| abstract |
A medicine for the effective treatment and/or improvement of sepsis in patients suffering from severe sepsis who have damage to one or more organs and the International Normalized Ratio (INR) value of a blood sample of whom is higher than 1.4, comprising thrombomodulin as active ingredient. |
| priorityDate |
2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |